2025 Program

Resident hands-on prosthetics course sponsored by Boston Scientific
Faculty: Brian Inouye, MD, Mike Pignanelli, MD, Chuck Welliver, MD
Attendees: AMC residents and fellows from surrounding programs
Thursday didactic program is co-sponsored by Boston Scientific and Coloplast
Dinner to follow hosted by Boston Scientific

SESSION 1
Moderator: Barry Kogan, MD

Navigating BCG unresponsive bladder cancer
Edward Messing, MD

What does the horizon look like for bladder cancer care?
Rob Siemens, DMD

SESSION 2
Moderator: Ronald Kaufman, Jr., MD

What is new in prostate biopsy
Isaac Kim, MD

Focal therapy for prostate cancer
Badar Mian, MD

Debate: elevated PSA but no target on MRI
Moderator: Ronald Kaufman JR., MD
Biopsy anyways: Rob Siemens, DMD
No biopsy: Edward Messing, MD

COFFEE BREAK, VISIT EXHIBITS
Saratoga 1

SESSION 3
Moderator: Brian Inouye, MD

Management of the complications that occur with laparoscopic and robotic surgery
Jean Joseph, MD, MBA

Urodynamics-patient mismatch: when to listen to the patient and when to listen to the study
Elise De, MD

Panel: What is the best use of APPs in a urology practice?
Moderator: Brian Inouye, MD
Panelists: Jean Joseph, MD, MBA, Isaac Kim, MD, Karla Giramonti, FNP, MS, Angela Motler

INDUSTRY LUNCH SYMPOSIUM (NOT FOR CME)
Head-to-head overall survival data in mCSPC: A review of real-world evidence
Speaker: Christopher Pieczonka, MD
Johnson & Johnson is a global healthcare leader, committed to solving the toughest health challenges and transforming lives through research, development, manufacture and distribution of innovative medicines and medical technologies.

SESSION 4
Moderator: Badar Mian, MD

Welliver: A practical approach to testosterone replacement
R. Charles Welliver, MD

Resident Debate:
Moderator: Badar Mian, MD
DRE is still helpful for prostate cancer detection/surveillance: RESIDENT
DRE finds too many problems you don't want to find: RESIDENT

SESSION 5
Moderator: R. Charles Welliver, MD

Cardiac health and erectile function: myths, realities and recommendations
Hossein Sadeghi-Nejad, MD, FACS

The best Peyronie’s Disease and Erectile Dysfunction papers from the last year
Michael Pignanelli, MD

BREAKFAST SYMPOSIUM:
Advancing Treatment in mCRPC: What Urologists Should Know About PLUVICTO, the First and Only PSMA-Targeted Therapy NOW APPROVED Prior to Chemotherapy
Harvard Huynh, PharmD, RUCIF, Manager, Medical Science Liaison – RLT, Novartis Pharmaceuticals Corporation
Sponsored by Novartis Pharmaceuticals Corporation

SESSION 6
Moderator: R. Charles Welliver, MD

Impact of GLP-1 Agonists on Male Reproductive Health
Hossein Sadeghi-Nejad, MD, FACS

Debate: Penile rehabilitation after radical prostatectomy
Moderator: R. Charles Welliver, MD
Too many challenges: Michael Pignanelli, MD
The data supports it: Hossein Sadeghi-Nejad, MD, FACS

COFFEE BREAK, VISIT EXHIBITS
Saratoga 1

SESSION 7
Moderator: Adrien Bernstein, MD

Managing upper tract urothelial carcinoma
Ronald Kaufman, Jr., MD

Trial updates on advanced prostate cancer
Isaac Kim, MD

Panel: How would you manage this patient’s PSA persistence after prostate cancer treament? A case based discussion on the use of PSMA/PET
Moderator: Adrien Bernstein, MD
Panelists: Badar Mian, MD, Jean Joseph, MD, MBA, Isaac Kim, MD, Ronald Kaufman, Jr., MD

SESSION 8
Moderator: Mark White, MD

Management of recurrent or advanced prostate cancer
Jillian Egan Kelly, MD

A practical approach to testosterone replacement
R. Charles Welliver, MD

BREAKFAST SYMPOSIUM:
ZUSDURI: The first and only FDA-approved medication for adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC)
Sponsored by Urogen

SESSION 9
Moderator: Michael Pignanelli, MD

Implementing smoking cessation in urologic oncology patients
Adrien Bernstein, MD

The present and future of medical publishing
Rob Siemens, DMD

Pelvic and perineal anatomy for the urologist
Brian Inouye, MD

Is there value in making sure your patient is 100% “stone free”?
Mark White, MD